Astrovirus infects actively secreting goblet cells and alters the gut mucus barrier.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
29 04 2020
Historique:
received: 24 10 2019
accepted: 08 04 2020
entrez: 1 5 2020
pubmed: 1 5 2020
medline: 30 7 2020
Statut: epublish

Résumé

Astroviruses are a global cause of pediatric diarrhea, but they are largely understudied, and it is unclear how and where they replicate in the gut. Using an in vivo model, here we report that murine astrovirus preferentially infects actively secreting small intestinal goblet cells, specialized epithelial cells that maintain the mucus barrier. Consequently, virus infection alters mucus production, leading to an increase in mucus-associated bacteria and resistance to enteropathogenic E. coli colonization. These studies establish the main target cell type and region of the gut for productive murine astrovirus infection. They further define a mechanism by which an enteric virus can regulate the mucus barrier, induce functional changes to commensal microbial communities, and alter host susceptibility to pathogenic bacteria.

Identifiants

pubmed: 32350281
doi: 10.1038/s41467-020-15999-y
pii: 10.1038/s41467-020-15999-y
pmc: PMC7190700
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2097

Subventions

Organisme : NIAID NIH HHS
ID : R21 AI135254
Pays : United States
Organisme : NIAID NIH HHS
ID : T32 AI106700
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA021765
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI136514
Pays : United States
Organisme : NIAID NIH HHS
ID : R03 AI126101
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI121832
Pays : United States

Références

Collaborators, G. D. D. Estimates of global, regional, and national morbidity, mortality, and aetiologies of diarrhoeal diseases: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Infect. Dis. 17, 909–948 (2017).
doi: 10.1016/S1473-3099(17)30276-1
Vu, D.-L., Bosch, A., Pintó, R. M. & Guix, S. Epidemiology of classic and novel human astrovirus: gastroenteritis and beyond. Viruses 9, 33 (2017).
pmcid: 5332952 doi: 10.3390/v9020033 pubmed: 5332952
Olortegui, M. P. et al. Astrovirus infection and diarrhea in 8 countries. Pediatrics 141, e20171326 (2018).
Cortez, V. et al. Astrovirus biology and pathogenesis. Annu Rev. Virol. 4, 327–348 (2017).
pubmed: 28715976 doi: 10.1146/annurev-virology-101416-041742
Cortez, V. et al. Characterizing a murine model for astrovirus using viral isolates from persistently infected immunocompromised mice. J. Virol. 93, e00223-19 (2019).
Sebire, N. J. et al. Pathology of astrovirus associated diarrhoea in a paediatric bone marrow transplant recipient. J. Clin. Pathol. 57, 1001–1003 (2004).
pubmed: 15333670 pmcid: 1770412 doi: 10.1136/jcp.2004.017178
Behling-Kelly, E. et al. Localization of astrovirus in experimentally infected turkeys as determined by in situ hybridization. Vet. Pathol. 39, 595–598 (2002).
pubmed: 12243474 doi: 10.1354/vp.39-5-595
Karam, S. M. Lineage commitment and maturation of epithelial cells in the gut. Front. Biosci. 4, D286–298 (1999).
pubmed: 10077541 doi: 10.2741/A426
Birchenough, G. M. H., Johansson, M. E. V., Gustafsson, J. K., Bergström, J. H. & Hansson, G. C. New developments in goblet cell mucus secretion and function. Mucosal Immunol. 8, 712–719 (2015).
pubmed: 25872481 pmcid: 4631840 doi: 10.1038/mi.2015.32
Cornick, S., Kumar, M., Moreau, F., Gaisano, H. & Chadee, K. VAMP8-mediated MUC2 mucin exocytosis from colonic goblet cells maintains innate intestinal homeostasis. Nat. Commun. 10, 4306 (2019).
pubmed: 31541089 pmcid: 6754373 doi: 10.1038/s41467-019-11811-8
Birchenough, G. M. H., Nyström, E. E. L., Johansson, M. E. V. & Hansson, G. C. A sentinel goblet cell guards the colonic crypt by triggering Nlrp6-dependent Muc2 secretion. Science 352, 1535–1542 (2016).
pubmed: 5148821 pmcid: 5148821 doi: 10.1126/science.aaf7419
Yazbeck, R., Howarth, G. S., Butler, R. N., Geier, M. S. & Abbott, C. A. Biochemical and histological changes in the small intestine of mice with dextran sulfate sodium colitis. J. Cell. Physiol. 226, 3219–3224 (2011).
pubmed: 21351101 doi: 10.1002/jcp.22682
Wlodarska, M. et al. Antibiotic treatment alters the colonic mucus layer and predisposes the host to exacerbated Citrobacter rodentium-induced colitis. Infect. Immun. 79, 1536–1545 (2011).
pubmed: 21321077 pmcid: 3067531 doi: 10.1128/IAI.01104-10
Rakoff-Nahoum, S., Paglino, J., Eslami-Varzaneh, F., Edberg, S. & Medzhitov, R. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 118, 229–241 (2004).
pubmed: 15260992 doi: 10.1016/j.cell.2004.07.002
Sharba, S. et al. Interleukin 4 induces rapid mucin transport, increases mucus thickness and quality and decreases colitis and Citrobacter rodentium in contact with epithelial cells. Virulence 10, 97–117 (2019).
pubmed: 30665337 pmcid: 6363059 doi: 10.1080/21505594.2019.1573050
Waddell, A., Vallance, J. E., Hummel, A., Alenghat, T. & Rosen, M. J. IL-33 induces murine intestinal goblet cell differentiation indirectly via innate lymphoid cell IL-13 secretion. J. Immunol. 202, 598–607 (2019).
pubmed: 30530480 doi: 10.4049/jimmunol.1800292
Wilen, C. B. et al. Tropism for tuft cells determines immune promotion of norovirus pathogenesis. Science 360, 204–208 (2018).
pubmed: 29650672 pmcid: 6039974 doi: 10.1126/science.aar3799
Pelaseyed, T. et al. The mucus and mucins of the goblet cells and enterocytes provide the first defense line of the gastrointestinal tract and interact with the immune system. Immunol. Rev. 260, 8–20 (2014).
pubmed: 24942678 pmcid: 24942678 doi: 10.1111/imr.12182
Schroeder, B. O. Fight them or feed them: how the intestinal mucus layer manages the gut microbiota. Gastroenterol. Rep. 7, 3–12 (2019).
doi: 10.1093/gastro/goy052
Sicard, J.-F., Le Bihan, G., Vogeleer, P., Jacques, M. & Harel, J. Interactions of intestinal bacteria with components of the intestinal mucus. Front. Cell Infect. Microbiol. 7, 387 (2017).
pubmed: 28929087 pmcid: 5591952 doi: 10.3389/fcimb.2017.00387
Arike, L. & Hansson, G. C. The densely O-glycosylated MUC2 mucin protects the intestine and provides food for the commensal bacteria. J. Mol. Biol. 428, 3221–3229 (2016).
pubmed: 26880333 pmcid: 4982847 doi: 10.1016/j.jmb.2016.02.010
Tailford, L. E., Crost, E. H., Kavanaugh, D. & Juge, N. Mucin glycan foraging in the human gut microbiome. Front. Genet. 6, 81 (2015).
pubmed: 25852737 pmcid: 4365749 doi: 10.3389/fgene.2015.00081
Derrien, M. et al. Mucin-bacterial interactions in the human oral cavity and digestive tract. Gut Microbes 1, 254–268 (2010).
pubmed: 21327032 pmcid: 3023607 doi: 10.4161/gmic.1.4.12778
Begley, M., Gahan, C. G. M. & Hill, C. The interaction between bacteria and bile. FEMS Microbiol. Rev. 29, 625–651 (2005).
doi: 10.1016/j.femsre.2004.09.003
Dupont, A. et al. Age-dependent susceptibility to enteropathogenic Escherichia coli (EPEC) infection in mice. PLoS Pathog. 12, e1005616 (2016).
pubmed: 27159323 pmcid: 4861285 doi: 10.1371/journal.ppat.1005616
Alvarado, D. M. et al. Epithelial indoleamine 2,3-dioxygenase 1 modulates aryl hydrocarbon receptor and notch signaling to increase differentiation of secretory cells and alter mucus-associated microbiota. Gastroenterology https://doi.org/10.1053/j.gastro.2019.07.013 (2019).
Bergstrom, K. S. B. et al. Muc2 protects against lethal infectious colitis by disassociating pathogenic and commensal bacteria from the colonic mucosa. PLoS Pathog. 6, e1000902 (2010).
pubmed: 20485566 pmcid: 2869315 doi: 10.1371/journal.ppat.1000902
Kolawole, A. O. et al. Astrovirus replication in human intestinal enteroids reveals multi-cellular tropism and an intricate host innate immune landscape. PLoS Pathog. 15, e1008057 (2019).
pubmed: 31671153 pmcid: 6957189 doi: 10.1371/journal.ppat.1008057
Kim, J. J. & Khan, W. I. Goblet cells and mucins: role in innate defense in enteric infections. Pathogens 2, 55–70 (2013).
pubmed: 25436881 pmcid: 4235714 doi: 10.3390/pathogens2010055
McGuckin, M. A., Lindén, S. K., Sutton, P. & Florin, T. H. Mucin dynamics and enteric pathogens. Nat. Rev. Microbiol. 9, 265–278 (2011).
pubmed: 21407243 doi: 10.1038/nrmicro2538
Good, C., Wells, A. I. & Coyne, C. B. Type III interferon signaling restricts enterovirus 71 infection of goblet cells. Sci. Adv. 5, eaau4255 (2019).
pubmed: 30854425 pmcid: 6402847 doi: 10.1126/sciadv.aau4255
Urbanelli, L. et al. The role of extracellular vesicles in viral infection and transmission. Vaccines 7, 102 (2019).
pmcid: 6789493 doi: 10.3390/vaccines7030102 pubmed: 6789493
Robinson, M., Schor, S., Barouch-Bentov, R. & Einav, S. Viral journeys on the intracellular highways. Cell. Mol. Life Sci. 75, 3693–3714 (2018).
pubmed: 30043139 pmcid: 6151136 doi: 10.1007/s00018-018-2882-0
Farkas, T., Fey, B., Keller, G., Martella, V. & Egyed, L. Molecular detection of novel astroviruses in wild and laboratory mice. Virus Genes 45, 518–525 (2012).
pubmed: 22899339 doi: 10.1007/s11262-012-0803-0
Ng, T. F. F. et al. Identification of an astrovirus commonly infecting laboratory mice in the US and Japan. PLoS ONE 8, e66937 (2013).
pubmed: 23825590 pmcid: 3692532 doi: 10.1371/journal.pone.0066937
Schmidt, K. et al. Development of a multiplex serological assay reveals a worldwide distribution of murine astrovirus infections in laboratory mice. PLoS ONE 12, e0187174 (2017).
pubmed: 29088279 pmcid: 5663422 doi: 10.1371/journal.pone.0187174
Ingle, H. et al. Viral complementation of immunodeficiency confers protection against enteric pathogens via interferon-λ. Nat. Microbiol. 4, 1120–1128 (2019).
pubmed: 30936486 pmcid: 6588490 doi: 10.1038/s41564-019-0416-7
Yokoyama, C. C. et al. Adaptive immunity restricts replication of novel murine astroviruses. J. Virol. 86, 12262–12270 (2012).
pubmed: 22951832 pmcid: 3486451 doi: 10.1128/JVI.02018-12
Marvin, S. A. et al. Type I interferon response limits astrovirus replication and protects against increased barrier permeability in vitro and in vivo. J. Virol. 90, 1988–1996 (2016).
pubmed: 26656701 pmcid: 4733991 doi: 10.1128/JVI.02367-15
Haber, A. L. et al. A single-cell survey of the small intestinal epithelium. Nature 551, 333–339 (2017).
pubmed: 29144463 pmcid: 29144463 doi: 10.1038/nature24489
Gorzelak, M. A. et al. Methods for improving human gut microbiome data by reducing variability through sample processing and storage of stool. PLoS ONE 10, e0134802 (2015).
pubmed: 26252519 pmcid: 4529225 doi: 10.1371/journal.pone.0134802
Jeon, Y.-S., Park, S.-C., Lim, J., Chun, J. & Kim, B.-S. Improved pipeline for reducing erroneous identification by 16S rRNA sequences using the Illumina MiSeq platform. J. Microbiol. 53, 60–69 (2015).
pubmed: 25557481 doi: 10.1007/s12275-015-4601-y
Golob, J. L. et al. Stool microbiota at neutrophil recovery is predictive for severe acute graft vs host disease after hematopoietic cell transplantation. Clin. Infect. Dis. 65, 1984–1991 (2017).
pubmed: 29020185 pmcid: 5850019 doi: 10.1093/cid/cix699
Callahan, B. J. et al. DADA2: high-resolution sample inference from illumina amplicon data. Nat. Methods 13, 581–583 (2016).
pubmed: 27214047 pmcid: 27214047 doi: 10.1038/nmeth.3869
Cole, J. R. et al. Ribosomal Database Project: data and tools for high throughput rRNA analysis. Nucleic Acids Res. 42, D633–D642 (2014).
doi: 10.1093/nar/gkt1244
Matsen, F. A., Kodner, R. B. & Armbrust, E. V. pplacer: linear time maximum-likelihood and Bayesian phylogenetic placement of sequences onto a fixed reference tree. BMC Bioinform. 11, 538 (2010).
doi: 10.1186/1471-2105-11-538
McCoy, C. O. & Matsen, F. A. Abundance-weighted phylogenetic diversity measures distinguish microbial community states and are robust to sampling depth. PeerJ 1, e157 (2013).
pubmed: 24058885 pmcid: 3775626 doi: 10.7717/peerj.157
Matsen, F. A. & Evans, S. N. Edge principal components and squash clustering: using the special structure of phylogenetic placement data for sample comparison. PLoS ONE 8, e56859 (2013).
pubmed: 23505415 doi: 10.1371/journal.pone.0056859

Auteurs

Valerie Cortez (V)

Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, TN, USA.

David F Boyd (DF)

Department of Immunology, St. Jude Children's Research Hospital, Memphis, TN, USA.

Jeremy Chase Crawford (JC)

Department of Immunology, St. Jude Children's Research Hospital, Memphis, TN, USA.

Bridgett Sharp (B)

Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, TN, USA.

Brandi Livingston (B)

Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, TN, USA.

Hannah M Rowe (HM)

Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, TN, USA.

Amy Davis (A)

Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, TN, USA.

Ramzi Alsallaq (R)

Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, TN, USA.

Camenzind G Robinson (CG)

Cell and Tissue Imaging Center, St. Jude Children's Research Hospital, Memphis, TN, USA.

Peter Vogel (P)

Veterinary Pathology Core, St. Jude Children's Research Hospital, Memphis, TN, USA.

Jason W Rosch (JW)

Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, TN, USA.

Elisa Margolis (E)

Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, TN, USA.

Paul G Thomas (PG)

Department of Immunology, St. Jude Children's Research Hospital, Memphis, TN, USA.

Stacey Schultz-Cherry (S)

Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, TN, USA. stacey.schultz-cherry@stjude.org.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH